184 related articles for article (PubMed ID: 33748733)
1. Proinsulin:C-peptide ratio trajectories over time in relatives at increased risk of progression to type 1 diabetes.
Triolo TM; Pyle L; Seligova S; Yu L; Simmons K; Gottlieb P; Evans-Molina C; Steck AK
J Transl Autoimmun; 2021; 4():100089. PubMed ID: 33748733
[TBL] [Abstract][Full Text] [Related]
2. Unmethylated Insulin as an Adjunctive Marker of Beta Cell Death and Progression to Type 1 Diabetes in Participants at Risk for Diabetes.
Simmons KM; Fouts A; Pyle L; Clark P; Dong F; Yu L; Usmani-Brown S; Gottlieb P; Herold KC; Steck AK;
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398795
[TBL] [Abstract][Full Text] [Related]
3. The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies.
Sosenko JM; Yu L; Skyler JS; Krischer JP; Gottlieb PA; Boulware D; Miao D; Palmer JP; Steck AK
Diabetes Technol Ther; 2017 Mar; 19(3):183-187. PubMed ID: 28177779
[TBL] [Abstract][Full Text] [Related]
4. Association of High-Affinity Autoantibodies With Type 1 Diabetes High-Risk HLA Haplotypes.
Triolo TM; Pyle L; Broncucia H; Armstrong T; Yu L; Gottlieb PA; Steck AK
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1510-e1517. PubMed ID: 34850014
[TBL] [Abstract][Full Text] [Related]
5. Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?
Fouts A; Pyle L; Yu L; Miao D; Michels A; Krischer J; Sosenko J; Gottlieb P; Steck AK;
Diabetes Care; 2016 Oct; 39(10):1738-44. PubMed ID: 27456836
[TBL] [Abstract][Full Text] [Related]
6. ECL-IAA and ECL-GADA Can Identify High-Risk Single Autoantibody-Positive Relatives in the TrialNet Pathway to Prevention Study.
Steck AK; Fouts A; Miao D; Zhao Z; Dong F; Sosenko J; Gottlieb P; Rewers MJ; Yu L;
Diabetes Technol Ther; 2016 Jul; 18(7):410-4. PubMed ID: 26991969
[TBL] [Abstract][Full Text] [Related]
7. High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes.
Jia X; He L; Miao D; Waugh K; Rasmussen CG; Dong F; Steck AK; Rewers M; Yu L
J Clin Endocrinol Metab; 2021 Nov; 106(12):3455-3463. PubMed ID: 34343303
[TBL] [Abstract][Full Text] [Related]
8. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
Dittler J; Seidel D; Schenker M; Ziegler AG
Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
[TBL] [Abstract][Full Text] [Related]
9. Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk.
Miao D; Steck AK; Zhang L; Guyer KM; Jiang L; Armstrong T; Muller SM; Krischer J; Rewers M; Yu L;
Diabetes Technol Ther; 2015 Feb; 17(2):119-27. PubMed ID: 25562486
[TBL] [Abstract][Full Text] [Related]
10. Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes.
Gu Y; Jia X; Vartak T; Miao D; Dong F; Jerram ST; Rewers M; Ferrara A; Lawrence JM; Yu L; Leslie RD;
Diabetologia; 2021 Sep; 64(9):2052-2060. PubMed ID: 34272582
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects.
Wenzlau JM; Walter M; Gardner TJ; Frisch LM; Yu L; Eisenbarth GS; Ziegler AG; Davidson HW; Hutton JC
J Clin Endocrinol Metab; 2010 Oct; 95(10):4712-9. PubMed ID: 20610599
[TBL] [Abstract][Full Text] [Related]
12. Proinsulin/Insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity.
Yu L; Dong F; Miao D; Fouts AR; Wenzlau JM; Steck AK
Diabetes Care; 2013 Aug; 36(8):2266-70. PubMed ID: 23423694
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against islet cell antigens in children with type 1 diabetes mellitus.
Cheng BW; Lo FS; Wang AM; Hung CM; Huang CY; Ting WH; Yang MO; Lin CH; Chen CC; Lin CL; Wu YL; Lee YJ
Oncotarget; 2018 Mar; 9(23):16275-16283. PubMed ID: 29662644
[TBL] [Abstract][Full Text] [Related]
14. Zinc transporter-8 autoantibodies can replace IA-2 autoantibodies as a serological marker for juvenile onset type 1 diabetes in India.
Shivaprasad C; Mittal R; Dharmalingam M; Kumar PK
Indian J Endocrinol Metab; 2014 May; 18(3):345-9. PubMed ID: 24944929
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of islet autoantibodies in Thai juvenile-onset type 1 diabetes.
Trisorus C; Aroonparkmongkol S; Kongmanas HB; Sahakitrungruang T
Pediatr Int; 2018 Nov; 60(11):1002-1007. PubMed ID: 30151912
[TBL] [Abstract][Full Text] [Related]
16. Elevations in the Fasting Serum Proinsulin-to-C-Peptide Ratio Precede the Onset of Type 1 Diabetes.
Sims EK; Chaudhry Z; Watkins R; Syed F; Blum J; Ouyang F; Perkins SM; Mirmira RG; Sosenko J; DiMeglio LA; Evans-Molina C
Diabetes Care; 2016 Sep; 39(9):1519-26. PubMed ID: 27385327
[TBL] [Abstract][Full Text] [Related]
17. Ten years follow up of first degree relatives of type 1 diabetes patients: presence of autoimmune biomarkers and the progression to diabetes in a retrospective cohort.
Leão IS; Araujo DB; Barone B; Dantas JR; de Souza Nolasco da Silva MV; Soares MO; Kendler DB; Kupfer R; Zajdenverg L; Rodacki M
Arch Endocrinol Metab; 2021 Nov; 65(4):436-442. PubMed ID: 34283897
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies.
Strollo R; Vinci C; Napoli N; Fioriti E; Maddaloni E; Åkerman L; Casas R; Pozzilli P; Ludvigsson J; Nissim A
Diabetes Metab Res Rev; 2019 May; 35(4):e3132. PubMed ID: 30693639
[TBL] [Abstract][Full Text] [Related]
19. A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.
Endesfelder D; Hagen M; Winkler C; Haupt F; Zillmer S; Knopff A; Bonifacio E; Ziegler AG; Zu Castell W; Achenbach P
Diabetologia; 2016 Oct; 59(10):2172-80. PubMed ID: 27400691
[TBL] [Abstract][Full Text] [Related]
20. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.
Giannopoulou EZ; Winkler C; Chmiel R; Matzke C; Scholz M; Beyerlein A; Achenbach P; Bonifacio E; Ziegler AG
Diabetologia; 2015 Oct; 58(10):2317-23. PubMed ID: 26138334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
